(Q33394044)

English

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

catastrophic antiphospholipid syndrome

0 references

thrombocytopenia

1 reference

based on heuristic

inferred from title

Yehuda Shoenfeld

11

object named as

Y Shoenfeld

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gisele Zandman-Goddard

10

object named as

G Zandman-Goddard

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ricard Cervera i Segura

1

object named as

R Cervera

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gerard Espinosa

3

object named as

G Espinosa

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

M G Tektonidou

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A R Cabral

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

E B González

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

D Erkan

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

S Vadya

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

H E Adrogué

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

M Solomon

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

174-181

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

The hematologic manifestations of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

(NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Characterization of beta2-glycoprotein I-dependent and -independent "antiphospholipid" antibodies from lupus-prone NZW/BXSB F1 hybrid male mice.

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Antiphospholipid antibodies in adults with immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Anticardiolipin antibodies in autoimmune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic?

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Antiphospholipid syndrome: pathogenic mechanisms

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

The antiphospholipid antibody syndrome in the emergency department setting — Livedo reticularis and recurrent venous thrombosis

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Cutaneous manifestations of antiphospholipid antibody syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

The geoepidemiology of the antiphospholipid antibody syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Antiphospholipid syndrome and the skin

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Sneddon's syndrome: generalized livedo reticularis and cerebrovascular disease. Importance of hemostatic screening

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

CEREBRO-VASCULAR LESIONS AND LIVEDO RETICULARIS

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Anetoderma and its prothrombotic abnormalities

1 reference

https://api.crossref.org/works/10.1177%2F0961203310395052

21 January 2018

Identifiers

10.1177/0961203310395052

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33394044&oldid=1644260210"